These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18596934)

  • 21. The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).
    Escolar E; Lamas GA; Mark DB; Boineau R; Goertz C; Rosenberg Y; Nahin RL; Ouyang P; Rozema T; Magaziner A; Nahas R; Lewis EF; Lindblad L; Lee KL
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):15-24. PubMed ID: 24254885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects.
    Lei Y; Nosoudi N; Vyavahare N
    J Control Release; 2014 Dec; 196():79-86. PubMed ID: 25285609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative medicine. NIH trial to test chelation therapy.
    Holden C
    Science; 2002 Aug; 297(5584):1109. PubMed ID: 12183605
    [No Abstract]   [Full Text] [Related]  

  • 24. EDTA chelation therapy meets evidence-based medicine.
    Lamas GA; Hussein SJ
    Complement Ther Clin Pract; 2006 Aug; 12(3):213-5. PubMed ID: 16835033
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy.
    Anderson TJ; Hubacek J; Wyse DG; Knudtson ML
    J Am Coll Cardiol; 2003 Feb; 41(3):420-5. PubMed ID: 12575969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chelation therapy for atherosclerotic cardiovascular disease.
    Villarruz MV; Dans A; Tan F
    Cochrane Database Syst Rev; 2002; (4):CD002785. PubMed ID: 12519577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chelation therapy in the treatment of cardiovascular diseases.
    Ibad A; Khalid R; Thompson PD
    J Clin Lipidol; 2016; 10(1):58-62. PubMed ID: 26892121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Another test, another disappointment for chelation therapy.
    Heart Advis; 2003 Apr; 6(4):2. PubMed ID: 12739442
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation on curative effects of ethylene diamine tetra-acetic acid chelation therapy in treating with atherosclerotic cardiovascular disease: A protocol for systematic review and meta-analysis.
    Song T; Zhang D
    Medicine (Baltimore); 2020 Dec; 99(52):e23346. PubMed ID: 33350725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EDTA chelation therapy for cardiovascular disease: a systematic review.
    Seely DM; Wu P; Mills EJ
    BMC Cardiovasc Disord; 2005 Nov; 5():32. PubMed ID: 16262904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
    Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
    Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chelation treatment of atherosclerosis.
    Magee R
    Med J Aust; 1985 Apr; 142(9):514-5. PubMed ID: 3921813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005.
    Brown MJ; Willis T; Omalu B; Leiker R
    Pediatrics; 2006 Aug; 118(2):e534-6. PubMed ID: 16882789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
    Navas-Acien A; Santella RM; Joubert BR; Huang Z; Lokhnygina Y; Ujueta F; Gurvich I; LoIacono NJ; Ravalli F; Ward CD; Jarrett JM; Salazar AL; Boineau R; Jones TLZ; Mark DB; Newman JD; Nathan DM; Anstrom KJ; Lamas GA
    Am Heart J; 2024 Jul; 273():72-82. PubMed ID: 38621575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric fatality secondary to EDTA chelation.
    Baxter AJ; Krenzelok EP
    Clin Toxicol (Phila); 2008 Dec; 46(10):1083-4. PubMed ID: 18949650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
    Lamas GA; Navas-Acien A; Mark DB; Lee KL
    J Am Coll Cardiol; 2016 May; 67(20):2411-2418. PubMed ID: 27199065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chelation therapy for cardiovascular disease. Review and commentary.
    Lewin MR
    Tex Heart Inst J; 1997; 24(2):81-9. PubMed ID: 9205980
    [No Abstract]   [Full Text] [Related]  

  • 38. Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).
    Nissen SE
    JAMA; 2013 Mar; 309(12):1293-4. PubMed ID: 23532246
    [No Abstract]   [Full Text] [Related]  

  • 39. Fatalities after CAM: an overview.
    Ernst E
    Br J Gen Pract; 2011 Jun; 61(587):404-5. PubMed ID: 21801529
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.
    Bauchner H; Fontanarosa PB; Golub RM
    JAMA; 2013 Mar; 309(12):1291-2. PubMed ID: 23532245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.